IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cells

Journal of Molecular Medicine

Volumn 85, Issue 7, 2007, Pages 707-721

  Amato, Rosario ^a   Menniti, Miranda ^a   Agosti, Valter ^a   Boito, Rosalia ^a   Costa, Nicola ^a   Bond, Heather M ^a   Barbieri, Vito ^a   Tagliaferri, Pierosandro ^a   Venuta, Salvatore ^a   Perrotti, Nicola ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Apoptosis; Cell proliferation; Interleukin 2; Kidney cancer cells; Sgk1

Indexed keywords

INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SERUM AND GLUCOCORTICOID REGULATED KINASE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SURVIVAL; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY CANCER; MALE; MOUSE; NONHUMAN; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS REGULATION; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TUMOR CELL;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERLEUKIN-2; KIDNEY NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION;

EID: 34447330960     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-007-0205-2     Document Type: Article

References (53)

1. David D, Bani L, Moreau JL, Treilhou MP, Nakarai T, Joussemet M, Ritz J, Dupont B, Pialoux G, Theze J (1998) Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy. Proc Natl Acad Sci USA 95:11348-11353
2. Upton MP, Parker RA, Youmans A, McDermott DF, Atkins MB (2005) Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy. J Immunother 28:488-495
3. Bazan JF (1992) Unraveling the structure of IL-2. Science 257:410-412
4. Kelly E, Won A, Refaeli Y, Van Parijs L (2002) IL-2 and related cytokines can promote T cell survival by activating AKT1. J Immunol 168:597-603
5. Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME (2001) Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 21:952-965
6. Kobayashi T, Cohen P (1999) Activation of serum- and glucocorticoid- regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2. Biochem J 339:319-328
7. Perrotti N, He RA, Phillips SA, Haft CR, Taylor SI (2001) Activation of serum-and glucocorticoid-induced protein kinase (Sgk) by cyclic AMP and insulin. J Biol Chem 276:9406-9412
8. Frodin M, Antal TL, Dummler BA, Jensen CJ, Deak M, Gammeltoft S, Biondi RM (2002) A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation. EMBO J 21:5396-5407
9. Menniti M, Iuliano R, Amato R, Boito R, Corea M, Le Pera I, Gulletta E, Fuiano G, Perrotti N (2005) Serum and glucocorticoid-regulated kinase Sgk1 inhibits insulin-dependent activation of phosphomannomutase 2 in transfected COS-7 cells. Am J Physiol Cell Physiol 288:C148-C155
10. Leong ML, Maiyar AC, Kim B, O'Keeffe BA, Firestone GL (2003) Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells. J Biol Chem 278:5871-5882
11. Maiyar AC, Huang AJ, Phu PT, Cha HH, Firestone GL (1996) p53 stimulates promoter activity of the sgk. serum/glucocorticoid-inducible serine/threonine protein kinase gene in rodent mammary epithelial cells. J Biol Chem 271:12414-12422
12. Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T, Conzen SD (2004) Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res 64:1757-1764
13. Zheng, Li D-C, Zhang Z-D, Zhao J, Ge J-F (2005) Anti-gastric cancer active immunity induced by FasL/B7-1gene-modified tumor cells. World J Gastroenterol 11:3204-3211:1757-1764
14. Suminami Y, Kashii Y, Law JC, Lin WC, Stanson J, Reichert TE, Rabinowich H, Whiteside TL (1988) Molecular analysis of the IL-2 receptor beta chain gene expressed in human tumor cells. Oncogene 16:1309-1317
15. Christoffersen CT, Bornefeldt KE, Rotella CM, Gonzales N Vissing H, Shymko RM, Hoeve JT, Groffen J, Heisterkamp N, De Meyts P (1994) Negative cooperativity in the insulin-like growth factor-I receptor and a chimeric IGF-I/insulin receptor. Endocrinology 1:472-475
16. Shikama Y, U M, Miyashita T, Yamada M (2001) Comprehensive studies on subcellular localization and cell death inducing activities of eight GFP-tagged apoptosis related caspase. Exp Cell Res 264:315-325
17. Waldegger S, Barth P, Raber G, Lang F (1997) Cloning and characterization of a putative human serine/threonine protein kinase transcriptionally modified during anisotonic and isotonic alterations of cell volume. Proc Natl Acad Sci USA 94:4440-4445
18. Schimpl A, Berberich I, Kneitz B, Kramer S, Santner-Nanan B, Wagner S, Wolf M, Hunig T (2002) IL-2 and autoimmune disease. Cytokine Growth Factor Rev 13:369-378
19. Lesur O, Brisebois M, Thibodeau A, Chagnon F, Lane D, Fullop T (2004) Role of IFN-gamma and IL-2 in rat lung epithelial cell migration and apoptosis after oxidant injury. Am J Physiol Lung Cell Mol Physiol 286:L4-L14
20. Fukushima K, Hara-Kuge S, Ideo H, Yamashita K (2001) Carbohydrate recognition site of interleukin-2 in relation to cell proliferation. J Biol Chem 276:31202-31208
21. Sharon M, Siegel JP, Tosato G, Yodoi J, Gerrard TL, Leonard WJ (1988) The human interleukin 2 receptor beta chain (p70). Direct identification, partial purification, and patterns of expression on peripheral blood mononuclear cells. J Exp Med 167:1265-1270
22. Weissman AM, Harford JB, Svetlik PB, Leonard WL, Depper JM, Waldmann TA, Greene WC, Klausner RD (1986) Only high-affinity receptors for interleukin 2 mediate internalization of ligand. Proc Natl Acad Sci USA 83:1463-1466
23. c receptors. Science 310:1159-1163
24. Kradin RL, Xia W, Pike M, Byers HR, Pinto C (1996) Interleukin-2 promotes the motility of dentric cells and their accumulation in lung and skin. Pathobiology 64:180-186
25. Thèze J, Alzari PM, Bortoglio J (1996) Intereleukin 2 and its receptor recent advances and new immunological functions. Immunol Today 17:481-484
26. Reinecker HC, Podolsky D (1995) Human intestinal epithelial cells express functional cytokine receptor sharing the common γc chain oh the IL-2 receptor. Proc Natl Acad Sci USA 92:8353-8357
27. McMillian DN, Kernohan NM, Flett ME, Heys SD, Deehan DJ, Sewell HF, Walker F, Eremin O (1995) Interleukin-2 receptor expresion in human solid tumor cells in situ and in vitro: evidence for a direct role in regulation of tumor cell proliferation. Int J Cancer 60:766-772
28. Vamosi G, Bodnar A, Vereb G, Jenei A, Goldman CK, Langowski J, Toth K, Matyus L, Szollosi J, Waldmann TA, Damjanovich S (2004) IL-2 and IL-15 receptor alpha-subunits are coexpressed in a supramolecular receptor cluster in lipid rafts of T cells. Proc Natl Acad Sci USA 101:11082-11087
29. Robb RJ, Greene WC, Rusk CM (1984) Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen. J Exp Med 160:1126-1146
30. Gesbert F, Sauvonnet N, Dautry-Varsat A (2004) Clathrin-independent endocytosis and signalling of interleukin 2 receptors IL-2R endocytosis and signalling. Curr Top Microbiol Immunol 286:119-148
31. Morrone G, Bond HM, Cuomo C, Agosti V, Petrella A, Pagnano AM, Della Corte A, Marasco O, Venuta S (1995) Differential regulation of the expression of interleukin-2 receptor gamma-chain during the in vitro differentiation of human myeloid cells. Biochem J 308:909-914
32. Romerio F, Zella D (2002) MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b. FASEB J 16:1680-1682
33. Faletti CJ, Perrotti N, Taylor SI, Blazer-Yost BL (2002) sgk: an essential convergence point for peptide and steroid hormone regulation of ENaC-mediated Na+ transport. Am J Physiol Cell Physiol 282:C494-C500
34. Sakoda H, Gotoh Y, Katagiri H, Kurokawa M, Ono H, Onishi Y, Anai M, Ogihara T, Fujishiro M, Fukushima Y, Abe M, Shojima N, Kikuchi M, Oka Y, Hirai H, Asano T (2003) Differing roles of Akt and serum and glucocorticoid-regulated kinase in glucose metabolism, DNA synthesis, and oncogenic activity. J Biol Chem 278:25802-25807
35. Vallon V, Lang F (2005) New insights into the role of serum- and glucocorticoid-inducible kinase SGK1 in the regulation of renal function and blood pressure. Curr Opin Nephrol Hypertens 14:59-66
36. Rauhala HE, Porkka KP, Tolonen TT, Martikainen PM, Tammela TL, Visakorpi T (2005) Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer. Int J Cancer 117:738-745
37. Biondi RM, Kieloch A, Currie RA, Deak M, Alessi DR (2001) The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB. EMBO J 20:4380-4390
38. Lang F, Cohen P (2001) Regulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoforms. Science's Signal Transduct Knowledge Environment 108:RE17
39. Park J, Leong ML, Buse P, Maiyar AC, Firestone GL, Hemmings BA (1999) Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. EMBO J 18:3024-3033
40. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, Cohen P (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha. Curr Biol 7:261-269
41. Lens SM, Kataoka T, Fortner KA, Tinel A, Ferrero I, MacDonald RH, Hahne M, Beermann F, Attinger A, Orbea HA, Budd RC, Tschopp J (2002) The caspase 8 inhibitor c-FLIP(L) modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Mol Cell Biol 22:5419-5433
42. Boehrer S, Kukoc-Zivojnov N, Nowak D, Bergmann M, Baum C, Puccetti E, Weidmann E, Hoelzer D, Mitrou PS, Chow KU (2004) Upon drug-induced apoptosis expression of prostate-apoptosis-response-gene-4 promotes cleavage of caspase-8, bid and mitochondrial release of cytochrome c. Hematology 9:425-431
43. Chen JS, Konopleva M, Andreeff M, Multani AS, Pathak S, Mehta K (2004) Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis. J Cell Physiol 200:223-234
44. Wu XX, Kakehi Y, Mizutani Y, Kamoto T, Kinoshita H, Isogawa Y, Terachi T, Ogawa O (2002) Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer. Int J Oncol 20:949-954
45. Tangir J, Bonafe N, Gilmore-Hebert M, Henegariu O, Chambers SK (2004) SGK1, a potential regulator of c-fms related breast cancer aggressiveness. Clin Exp Metastasis 21:477-483
46. Buse P, Tran SH, Luther E, Phu PT, Aponte GW, Firestone GL (1999) Cell cycle and hormonal control of nuclear-cytoplasmic localization of the serum- and glucocorticoid-inducible protein kinase, Sgk, in mammary tumor cells. A novel convergence point of anti-proliferative and proliferative cell signaling pathways. J Biol Chem 274:7253-7263
47. Waldegger S, Klingel K, Barth P, Sauter M, Rfer ML, Kandolf R, Lang F (1999) h-sgk serine-threonine protein kinase gene as transcriptional target of transforming growth factor beta in human intestine. Gastroenterology 116:1081-1088
48. Li W, Wang S, Chen C, Zhuang G (2006) Induction of tumor cell apoptosis via Fas/DR5. Cell Mol Immunol 3:467-471
49. Schickling O, Stegh AH, Byrd J, Peter ME (2001) Nuclear localization of DEDD leads to caspase-6 activation through its death effector domain and inhibition of RNA polymerase I dependent transcription. Cell Death Differ 8:1157-1168
50. Ferrando-May E (2005) Nucleocytoplasmic transport in apoptosis. Cell Death Differ 12:1236-1276
51. Besnault-Mascard L, Leprince C, Auffredou MT, Meunier B, Bourgeade MF, Camonis J, Lorenzo HK, Vazquez A (2005) Caspase-8 sumoylation is associated with nuclear localization. Oncogene 24:3268-3273
52. Nelson BH, Martyak TP, Thompson LJ, Moon JJ, Wang T (2003) Uncoupling of promitogenic and antiapoptotic functions of IL-2 by Smad-dependent TGF-beta signaling. J Immunol 170:5563-5570
53. Aoyama T, Matsui T, Novikov M, Park J, Hemmings B, Rosenzweig A (2005) Serum and glucocorticoid-responsive kinase-1 regulates cardiomyocyte survival and hypertrophic response. Circulation 111:1652-1659